Valuable Endpoints Beyond OS in Ovarian Cancer

November 30, 2017
Maurie Markman, MD

Maurie Markman, MD, president of medicine and science, Cancer Treatment Centers of America, discusses valuable endpoints beyond overall survival (OS) that can be used in ovarian cancer clinical trials.